Description
Harvard Medical School Diabetes Update 2023
Medical School Diabetes
Diabetes Update 2023
Live Streaming • May 3 – 6, 2023
The Harvard Medical School Diabetes Update
Diabetes Update will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.Â
EDUCATION to MEET THE CHALLENGES of DIABETES CARE
Medical School Diabetes
At a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?
The answer is rooted in four challenges:
- Keeping pace with rapidly advancing clinical options for diabetes care:
- Therapies
- Technologies
- Lifestyle medicine interventions
- Designing comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications
- Accounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors
- Overcoming structural healthcare barriers that require clinical strategies to fit within a particular mold
This course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.
STRATEGIES, UPDATES, and BEST PRACTICES for STATE-OF-THE-ART DIABETES CARE
Medical School Diabetes
This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.
Participants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:
- Design of more effective treatment plans
- Current anti-diabetes medications and how to use them
- Diagnosis of different types of diabetes
- Utilization of recent technology advances in diabetes care
- Optimizing care for people with obesity
- Assessing and treating cardiovascular and renal complications
- Guiding patients on physical activity and medical nutrition
- Management of hypertension and dyslipidemia
- Addressing low engagement in therapy
NEW DATA and PRACTICE GUIDELINES for DIABETES CARE
- The newest data on the identification of different types of diabetes
- The latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes
- New guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care
- Criteria to navigate the controversial data related to some anti-diabetes medications
- Medical vs. surgical management of obesity
- New technologies in diabetes care: updates and implications for day-to-day care
- Research breakthroughs
- Tips and tricks for navigating barriers within healthcare systems
ASSESSMENT and TREATMENT of COMPLICATIONS from DIABETES
The 2023 program provides education to assess and treat:
- Cardiovascular Disease
- Congestive Heart Failure
- Renal Disease
- Non-Alcoholic Liver Disease
OPTIMIZING HEALTH OUTCOMES for DIFFERENT PATIENTS
This program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.
Coverage includes:
- Racial and ethnic minorities
- The elderly
- People with obesity
- Patients at high cardiovascular risk
- Individuals with low engagement in therapy
- Patients at low socio-economic levels
- Subjects with low health literacy/education
- Individuals with depression/emotional distress
- Patients with metabolic liver disease
PRACTICE IMPACT
Over four days, you will gain new, encompassing, evidence-based approaches to address the challenges seen in most clinical practices. More importantly, you will leave with knowledge—part art, part science—to make a real difference in the lives of your patients.
OPTIMIZED for REMOTE EDUCATION
Medical School Diabetes The 2023 program has been enhanced for distance learning. In addition to being live streamed, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.
Along with recordings and course presentations, additional resources such as guidelines, recent articles and relevant patient education materials will also be available.
Schedule
All times listed below are Eastern Daylight Time.
| 9:30am to 9:45am | Welcome and IntroductionA. Enrique Caballero, MD |
| 9:45am to 10:15am | Diabetes Report Card: How Are We Doing in Diabetes Care?A. Enrique Caballero, MD |
| 10:15am to 10:35am | Practical Approach to Identifying Different Types of Diabetes in Clinical PracticeLucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC | |
| 10:35am to 10:55am | Current Understanding of Diabetes PhenotypesMiriam Udler, MD, PhD | |
| 10:55am to 11:10am | Break | |
| 11:10am to 11:50am | Q & A and Clinical Cases DiscussionLucia Novak, MSN, ANP-BC, BC-ADM, CDTC and Miriam Udler, MD, PhD |
| 11:50am to 12:10pm | Type 2 Diabetes in the Elderly: What You Need to KnowMedha Munshi, MD | |
| 12:10pm to 12:30pm | A Practical Approach to Anti-Diabetes Medication SelectionMarie McDonnell, MD | |
| 12:30pm to 1:10pm | Q & A and Clinical Cases DiscussionMedha Munshi, MD and Marie McDonnell, MD | |
| 1:10pm to 1:55pm | Break |
| 1:55pm to 2:15pm | Current Nutrition Recommendations and GuidelinesLaura Andromalos, MS, RD, RN, CSOWM, CDCES | |
| 2:15pm to 2:35pm | The Carbohydrate-Insulin Model: A Novel Approach to DiabesityDavid Ludwig, MD, PhD | |
| 2:35pm to 3:15pm | Q & A and Clinical Case DiscussionLaura Andromalos, MS, RD, CSOWM, CDCES and David Ludwig, MD, PhD | |
| 3:15pm to 3:45pm | Interactive Breakout Sessions |
| 9:30am to 9:40am | Welcome, Recap of Day 1, and Description of Day 2 ActivitiesA. Enrique Caballero, MD |
| 9:40am to 10:15am | Non-Alcoholic Fatty Liver DiseaseScott Isaacs, MD, FACP, FACE |
| 10:15am to 10:35am | Exercise in Diabetes Care: The Basics on What Works and WhyJane Reusch, MD | |
| 10:35am to 10:55am | Exercise Recommendations: Building a Tailored Program considering Diabetes Status and ComplicationsJacqueline Shahar, MEd, RCEP, CDCES | |
| 10:55am to 11:10am | Break | |
| 11:10am to 11:50am | Q & A and Clinical Case DiscussionJane Reusch, MD and Jacqueline Shahar, MEd, RCEP, CDCES |
| 11:50am to 12:10pm | Pharmacological Management: Individualizing TherapyW. Scott Butsch, MD, MSc | |
| 12:10pm to 12:30pm | Surgical Management: Why and When?Philip R. Schauer, MD | |
| 12:30pm to 1:10pm | Q & A and Clinical Cases DiscussionW. Scott Butsch, MD, MSc and Philip R. Schauer, MD | |
| 1:10pm to 1:55pm | Break |
| 1:55pm to 2:15pm | Addressing LDL: Cholesterol as Primary TargetOm Ganda, MD | |
| 2:15pm to 2:35pm | Triglycerides and HDL: Cholesterol Management—When and How?Aruna Pradhan, MD, MPH | |
| 2:35pm to 3:15pm | Q & A and Clinical Case DiscussionOm Ganda,MD and Aruna Pradhan, MD, MPH | |
| 3:15pm to 3:45pm | Interactive Breakout Sessions |
| 9:30am to 9:40am | Welcome, Recap of Day 2 and Description of Day 3 ActivitiesA. Enrique Caballero, MD |
| 9:40am to 10:15am | The Microbiome in Obesity, Diabetes, and Related DisordersPatricia Davidson, DCN, RDN, LDN, CDCES, FAND, CHSE, FADCES |
| 10:15am to 10:35am | Clinical Evaluation of the Patient with HypertensionNaomi Fisher, MD | |
| 10:35am to 10:55am | Current Recommendations for the Treatment of HypertensionJohn Forman, MD | |
| 10:55am to 11:10am | Break | |
| 11:10am to 11:50am | Q & A and Clinical Case DiscussionNaomi Fisher, MD and John Forman, MD |
| 11:50am to 12:10pm | Evaluation of CV Risk: Practical RecommendationsJorge Plutzky, MD | |
| 12:10pm to 12:30pm | Reducing CV Risk in the Patient with Diabetes: A Comprehensive ApproachChristopher Cannon, MD | |
| 12:30pm to 1:10pm | Q & A and Clinical Case DiscussionJorge Plutzky, MD and Christopher Cannon, MD | |
| 1:10pm to 1:55pm | Break |
| 1:55pm to 2:15pm | Continuous Glucose Monitoring: A 2023 VisionDevin Steenkamp, MD | |
| 2:15pm to 2:35pm | Insulin Pumps, Closing the Loop: Where Do We Stand?Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP | |
| 2:35pm to 3:15pm | Q & A and Clinical Cases DiscussionDevin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP | |
| 3:15pm to 3:45pm | Interactive Breakout Sessions |
| 9:30am to 9:40am | Welcome, Recap of Day 3 and Description of Day 4 ActivitiesA. Enrique Caballero, MD |
| 9:40am to 10:00am | Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)A. Enrique Caballero, MD | |
| 10:00am to 10:20am | Incretin-Based Therapies (DPP-IV Inhibitors and GLP-1 RA)Juan P. Frias, MD | |
| 10:20am to 10:40am | SGLT-2 InhibitorsSilvio Inzucchi, MD | |
| 10:40am to 11:00am | Insulin TherapyAnne L. Peters, MD | |
| 11:00am to 11:10am | Break | |
| 11:10am to 12:10pm | Q & A and Clinical Cases DiscussionA. Enrique Caballero, MD, Juan P. Frias, MD, Silvio Inzucchi, MD, and Anne L. Peters, MD | |
| 12:10pm to 1:10pm | Break |
| 1:10pm to 1:40pm | How Do Race and Ethnicity Influence Diabetes Management Decisions?A. Enrique Caballero, MD | |
| 1:40pm to 2:10pm | Identifying Community-Based Resources to Help Patients with DiabetesJosh Trautwein | |
| 2:10pm to 2:30pm | Q & A Clinical Cases DiscussionA. Enrique Caballero, MD |
| 2:30pm to 3:15pm | The Road towards Equity in Diabetes CareJanet Brown-Friday, RN, MSN, MPH | |
| 3:15pm to 3:45pm | Interactive Breakout Sessions | |
| 3:45pm to 3:50pm | Closing RemarksA. Enrique Caballero, MD |
